nitric oxide synthase are thought to be important for the fine adjustments of blood pressure. However, overBackground. Recently rat vascular smooth-muscle cells ( VSMC ) have been shown to possess Epo receptor, production of NO, as stimulated by bacterial endotoxins or cytokines, may cause the hypotension seen in and respond to various cytokines for producing nitric oxide (NO). In the present study we examined the sepsis [3,4]. NO activates guanylate cyclase in VSMC to generate intracellular cGMP, which causes subeffect of pharmacological dose of human recombinant erythropoietin (rHuEpo) on the IL-1b-induced NO sequent muscle relaxation. On the other hand, VSMC themselves produce NO in response to cytokines such and cGMP production as well as inducible nitric oxide synthase (iNOS) in cultured rat VSMC.
Introduction
iNOS mRNA expression in VSMC. [13] . In brief, cells were grown in Dulbecco's modified eagle ized filters were then exposed to Kodak XAR film overnight at −70°C with one intensifying screen. Autoradiography medium (DMEM ) supplemented with 10% fetal bovine serum (ICN Biomedicals, Osaka, Japan), 100 U/ml penicil-was performed at −70°C and quantified by densitometric scanning (Immunomedica Image Analyser TIF-64). The lin, and 100 mg/ml streptomycin (Life Technology Inc, USA). Cells grown to confluence were detached by a filter membranes were also hybridized with [c-32P]ATPlabelled rat glyceraldehyde-3-phosphate dehydrogenase olitreatment with 0.125% trypsin and 0.02% EDTA and reseeded in secondary cultures. Cells were used between gonucleotide probe. passages 5 and 10. Cells were plated at 1-2×104 cells/ml in 24-well dishes (Falcon) in DMEM supplemented as Measurement of intracellular cGMP contents described above and allowed to grow subconfluently for 48-72 h. They were then made 'quiescent' by a 24-h cGMP contents were determined as reported previously [10] . incubation in serum-free DMEM.
Briefly, the phosphodiesterase inhibitor, isobutylmethylxanAfter being rinsed with phosphate-buffered saline (PBS) thine (IBMX ), was added to each well at a final concentraat pH 7.35, confluent cells were incubated for 24 h with tion of 0.5 mM, immediately after measurements of nitrite. serum-and phenol-red-free DMEM containing 10 ng/ml After incubation for 15 min at 95% air-5% CO 2 in a humidihuman recombinant IL-1b with exceptions of the time-course fied incubator at 37°C, the medium was aspirated off and and dose-dependency studies. Agents such as Epo, Epo cells were immediately immersed in 0.2 ml of 0.1 N HCl to vehicle were added to the incubation medium concomitantly stop the reaction. Cells were collected into glass tubes with with IL-1b. a rubber policeman, boiled for 3 min, and then centrifuged at 2500 g for 15 min at room temperature. The supermatants were decanted and 0.05 ml of 50 mM sodium acetate was
Determination of nitrite
added to each tube. These were kept at −30°C until assay for cGMP contents. The pellets were dissolved in 0.2 ml of Nitrite was measured by the method of Green et al. [14] . In 1% sodium dodecyl sulphate and kept at −30°C until assay cell culture systems, NO degrades rapidly to nitrite, but in for protein. Intracellular cGMP contents were determined the presence of Fe2+ haem, or certain other transition metals.
using a cGMP enzyme immunoassay kit (Amersham) and nitrite is converted to the more stable product nitrate. In normalized to protein content of each well. The lower limit vivo nitrite seems to be unstable and has a short half-life of detection was 2 fmol/well. 
Assay for iNOS mRNA Statistics
Inducible NOS mRNA expression in VSMC was analysed by Northern blotting as reported previously [13] . Briefly, The results are expressed as mean±SEM (number of VSMC was grown to confluence on 100-mm dishes and lysed samples). Data were analysed by analysis of variance comusing Isogen@ (Nippon Gene, Tokyo, Japan), which con-bined with Fisher's PLSD. Differences with P<0.05 were tained phenol and guanidine isothiocyanate. The lysate was considered to be significant. Each figure is a representative extracted with chloroform/isopropanol, washed with 75% one of at least three separate experiments except for shown in Figure 1a , IL-1b alone linearly increased Effect of graded concentration of rHuEpo on IL-1b-induced nitrite and cGMP production nitrite production with significance over 24-h incubation. 250 U/ml rHuEpo inhibited IL-b-induced nitrite As shown in Figure 2a , nitrite production is fairly low production significantly over 24-h coincubation. The (36.1±2.7 nmol/mg protein) in the absence of IL-1b, average (28.8%) inhibition by rHuEpo was obtained whereas addition of 10 ng/ml IL-1b markedly enhanced at 24-h coincubation. On the other hand, cGMP pro-nitrite production (537.2±21.2 nmol/mg protein). In duction by DMEM, IL-1b, and IL-1b plus rHuEpo the presence of IL-1b, rHuEpo inhibited nitrite producwere monophasic, reaching maximal levels at 24 h of tion in a dose-dependent mannner with significance at exposure ( Figure 1b) ; 250 U/ml rHuEpo significantly concentration of 250 U/ml. On the other hand, in the inhibited IL-1b-induced cGMP production at 24-h absence of IL-1b, 250 U/ml rHuEpo did not affect coincubation. Therefore we incubated VSMC with the nitrite production at all. Like nitrite, rHuEpo inhibited test agents for 24 h in the subsequent experiments for cGMP production in a dose-dependent fashon with measurements of nitrite and cGMP production.
significance at concentration of 250 U/ml ( Figure 2b) . (a) Dose-response of rHuEpo on IL-1b-dependent or-independent nitrite production. VSMC were incubated with 25 production and IL-1b-independent nitrite production. VSMC were incubated with either IL-1b (10 ng/ml ) alone, IL-1b plus rHuEpo and 250 U/ml of rHuEpo for 24 h in the presence or absence of 10 ng/ml IL-1b. Column and bar represent mean±SEM of four (250 U/ml ) or DMEM for the time indicated. Each point is mean±SEM of four samples. *1 P<0.01 vs IL-1b+ rHuEpo; *2 samples. *1 P<0.01 vs DMEM; *2 P<0.01 vs IL-1b alone. (b) Dose response of rHuEpo on IL-1b-dependent or -independent P<0.01 vs DMEM. (b) Time course of IL-1b, IL-1b plus rHuEpoinduced cGMP production and IL-1b-independent cGMP produc-cGMP production. After measuring nitrite, VSMC were incubated with 0.5 mM IBMX for 15 min. Column and bar represents tion. After measuring nitrite, VSMC were incubated with 0.5 mM IBMX for 15 min. Each point is mean±SEM of four samples. *1 mean±SEM of four samples. *1 P<0.01 vs DMEM; *2 P<0.01 vs IL-1b alone. P<0.0l vs IL-1b+Epo; *2 P<0.01 vs DMEM.
In the absence of IL-1b, 250 U/ml rHuEpo did not nitrite production. As for cGMP production shown in Figure 3b , ANP stimulated cGMP production, whereas affect cGMP production at all. addition of rHuEpo to ANP did not modify the cGMP accumulation. Similar to ANP, SNP also stimulated Effect of rHuEpo on ANP-or SNP-stimulated nitrite cGMP production, whereas addition of rHuEpo to and cGMP production ANP did not modify the cGMP accumulation. We also examined the effects of rHuEpo on ANP-or SNP-stimulated nitrite and cGMP production in the Effect of rHuEpo and rHuEpo vehicle on IL-1b-induced absence of IL-1b to confirm that the effects of rHuEpo nitrite and cGMP production on nitrite and cGMP production are linked. As shown Next we investigated whether the inhibition by rHuEpo in Figure 3a , 10−6 M ANP itself did not stimulate may be due to some components of rHuEpo solvent. nitrite accumulation in the absence of IL-1b, whereas
For this we incubated VSMC with rHuEpo vehicle addition of rHuEpo to ANP did not affect nitrite that contained the same solution as the active rHuEpo production. On the other hand, 10−4 M SNP markedly vial. As shown in Figure 4a , rHuEpo vehicle did not stimulated nitrite production in the absence of IL-1b, inhibit IL-1b-dependent nitrite production, whereas whereas addition of rHuEpo to SNP did not affect 250 U/ml rHuEpo did inhibit IL-1b-induced nitrite production. Identical results were obtained for cGMP production ( Figure 4b ). This indicates that rHuEpo itself, and not its solvent, inhibits IL-1b-induced nitrite and cGMP production.
Effect of rHuEpo and rHuEpo vehicle on iNOS mRNA expression
We also examined the effects of rHuEpo and rHuEpo vehicle on iNOS mRNA expression. As shown in Figure 5 , 10 ng/ml of IL-1b markedly induced iNOS mRNA expression; 250 U/ml rHuEpo showed inhibition of iNOS mRNA expression induced by IL-1b, whereas rHuEpo vehicle did not affect iNOS mRNA expression.
Discussion
The present study clearly demonstrates for the first time that a pharmacological dose of rHuEpo inhibits IL-1b-induced NO and cGMP production as well as iNOS mRNA expression, presumably via Epo receptor. Ammarguellat et al. recently showed Epo receptor mRNA expression in cultured rat VSMC by using Northern blot analysis. From these results, it is reasonable to speculate that Epo may directly affect VSMC function through Epo receptor. Indeed, there are several reports demonstrating the direct effects of Epo on VSMC, showing mitogenic and vasocontractive effects of Epo in VSMC [11, 12] .
Although the rHuEpo concentrations used in this study are much higher than the plasma concentrations reached with therapeutic doses, such differences in concentrations between in vivo and in vitro are not exceptional. Further, a lower sensitivity of cultured VSMC can be expected in vitro than in vivo. In addition, in vivo hormone concentrations at the target sites may be much higher than the circulating concentration of the hormone. Indeed, it is reported that Epo concentra- It is a well-known fact that various vasoconstrictors such as NA, AII, ET and AVP cause vascular contraction in a direct manner. Recently, it has been shown that these substances may cause vasoconstriction indirectly through inhibiting cytokine-induced NO production [7] [8] [9] [10] . In contrast to these vasoconstrictors, vasodilating hormones such as ANP, PGI 2 and PGE 1 were shown to stimulate cytokine-induced NO production in VSMC [16, 21] . Therefore it is plausible that both vasoconstrictors and vasodilators seem to enhance their original functions through cytokineinduced NO production.
NO is known to activate soluble guanylate cyclase possibility is that the compounds such as rHuEpo and IL-1b are not stable for such a long period of time. Since not only cGMP production by IL-1b alone but also those of DMEM alone and IL-1b plus sensitivity of rHuEpo on nitrite production cannot be denied [19] . In clinical settings, relatively high rHuEpo rHuEpo show monophasic patterns, it may depend on some intrinsic factors that relate to the cGMP plasma concentrations, of the order of 1-5 U/ml, may be obtained intermittently in chronic haemodialysis system rather than a cytotoxic effect of NO or instability of the compounds used in the experiments. patients, at least immediately after intravenous injection of the hormone [20] . Therefore it is reasonable to However, the fact that the changes of NO and cGMP production were identical in the present study indispeculate that even pharmacological doses of rHuEpo may affect cytokine-induced nitrite metabolism in some cates that rHuEpo inhibition of NO and cGMP may have a physiological meaning in cardiovascular regulapatients undergoing chronic HD. are thought to be elevated [22, 23] 
